September 2025 – Endpoints News

Immuneering builds momentum with additional first-line pancreatic cancer data, aims for Phase 3 this year

Immuneering Corporation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.